Anti-Herpes Simplex virus and antibacterial activities of Graptopetalum paraguayense E. Walther leaf extract: a pilot study

References

• Fauci AS. Infectious diseases: considerations for the 21st century. Clin Infect Dis. 2001;32:675–685.
   PubMed Web of Science ®Google Scholar
• Wilson SS, Fakioglu E, Herold BC. Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti Infect Ther. 2009;7:559–568.
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis. 1998;26:541–555.
   PubMed Web of Science ®Google Scholar
• De Clercq E, Field HJ. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. Br J Pharm. 2006;147:1–11.
   PubMed Web of Science ®Google Scholar
• Kennedy PGE, Chaudhuri A. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 2002;73:237–238.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Koskela P, Jellum E, et al. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the Nordic countries. Am J Epidemiol. 2002;156:687–692.
   PubMed Web of Science ®Google Scholar
• Celum CL. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes: J IHMF. 2004;11:36a–45a.
   PubMedGoogle Scholar
• Almand EA, Moore MD, Jaykus L-A. Virus-bacteria interactions: an emerging topic in human infection. Viruses 2017;9:58.
   Web of Science ®Google Scholar
• Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother. 2011;55:459–472.
   PubMed Web of Science ®Google Scholar
• Frobert E, Cortay JC, Ooka T, et al. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res. 2008;79:28–36.
   PubMed Web of Science ®Google Scholar
• WHO. Antimicrobial resistance: global report on surveillance. France: World Health Organization; 2014.
   Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe – Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017 Antimicrobial resistance surveillance in Europe. Stockholm: ECDC; 2018.
   Google Scholar
• Raskin I, Ribnicky DM, Komarnytsky S, et al. Plants and human health in the twenty-first century. Trends Biotechnol. 2002;20:522–531. doi:10.1016/S0167-7799(02)02080-2.
   PubMed Web of Science ®Google Scholar
• Chen S-J, Yen C-H, Liu J-T, et al. Anti-inflammatory effect of water extracts of Graptopetalum paraguayense supplementation in subjects with metabolic syndrome: a preliminary study. J Sci Food Agric. 2016;96:1772–1776.
   PubMed Web of Science ®Google Scholar
• Chung Y-C, Chen S-J, Hsu C-K, et al. Studies on the antioxidative activity of Graptopetalum paraguayense E. Walther. Food Chem. 2005;91:419–424.
   Web of Science ®Google Scholar
• Hsu WH, Chang CC, Huang KW, et al. Evaluation of the medicinal herb Graptopetalum paraguayense as a treatment for liver cancer. PLoS ONE. 2015;10:e0121298.
   PubMed Web of Science ®Google Scholar
• Markova NV, Batovska DI, Kozuharova EK, et al. Anti-conjunctivitis effect of fresh juice of xGraptoveria (Crassulaceae): a phytochemical and ethnobotanical study. J Intercult Ethnopharmacol. 2015;4:24–28.
   PubMedGoogle Scholar
• Jhuang HJ, Hsu WH, Lin KT, et al. Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1alpha-dependent pathway. Oncotarget 2015;6:7788–7803.
   PubMedGoogle Scholar
• Chung Y-C, Chou S-T, Jhan J-K, et al. In vitro and in vivo safety of aqueous extracts of Graptopetalum paraguayense E. Walther. J Ethnopharmacol. 2012;140:91–97.
   PubMed Web of Science ®Google Scholar
• Orhan I, Deliorman-Orhan D, Özçelik B. Antiviral activity and cytotoxicity of the lipophilic extracts of various edible plants and their fatty acids. Food Chem. 2009;115:701–705. doi:10.1016/j.foodchem.2009.01.024.
   Web of Science ®Google Scholar
• Ürményi FGG, Saraiva GN, Casanova LM, et al. Anti-HSV-1 and HSV-2 flavonoids and a new kaempferol triglycoside from the medicinal plant Kalanchoe daigremontiana. Chem Biodivers. 2016;13:1707–1714.
   PubMed Web of Science ®Google Scholar
• Nwadinigwe AO. Antimicrobial activities of methanol and aqueous extracts of the stem of Bryophyllum pinnatum Kurz (Crassulaceae.). Afr J Biotechnol. 2011;10:16342–16346.
   Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27:493–497.
   Google Scholar
• Serkedjieva J, Hay AJ. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antivir Res. 1998;37:121–130.
   PubMed Web of Science ®Google Scholar
• Mosmann TR. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Sieuwerts AM, Klijn JG, Peters HA, et al. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolie activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. Eur J Clin Chem Clin Biochem. 1995;33:813–824.
   PubMedGoogle Scholar
• El-Toumy SA, Salib JY, El-Kashak WA, et al. Antiviral effect of polyphenol rich plant extracts on herpes simplex virus type 1. Food Sci Hum Wellness. 2018;7:91–101. doi:10.1016/j.fshw.2018.01.001.
   Google Scholar
• Takeuchi H, Baba M, Shigeta S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J Virol Methods. 1991;33:61–71. doi:10.1016/0166-0934(91)90008-N.
   PubMed Web of Science ®Google Scholar
• ISO20776/1-2006, Clinical laboratory testing and in vitro diagnostic test systems—susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases, 2006, p. 19. European Committee for Standardization (CEN), Technical Committee CEN/TC 140, Technical Committee ISO/TC 212.
   Google Scholar
• EUCAST [Internet]. Clinical breakpoints. Breakpoint tables for bacteria. European Society of Clinical Microbiology and Infectious Diseases; 2018. [updated 1 January 2019]. Available from: http://www.eucast.org/clinical_breakpoints/
   Google Scholar
• Stepanovic S, Vukovic D, Dakic I, et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40:175–179.
   PubMed Web of Science ®Google Scholar
• Lyu SY, Rhim JY, Park WB. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res. 2005;28:1293–1301.
   PubMed Web of Science ®Google Scholar
• Liu HY, Peng HY, Hsu SL, et al. Chemical characterization and antioxidative activity of four 3-hydroxyl-3-methylglutaroyl (HMG)-substituted flavonoid glycosides from Graptopetalum Paraguayense E. Walther. Bot Stud. 2015;56:8.
   PubMed Web of Science ®Google Scholar
• Wu S-C, Su Y-S, Cheng H-Y. Antioxidant properties of Lactobacillus-fermented and non-fermented Graptopetalum paraguayense E. Walther at different stages of maturity. Food Chem. 2011;129:804–809. doi:10.1016/j.foodchem.2011.05.025.
   PubMed Web of Science ®Google Scholar
• Varadinova T, Vilhelmova N, Badenas F, et al. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication. Acta Virol. 2005;49:251–260.
   PubMed Web of Science ®Google Scholar
• Duh P-D, Lin S-L, Wu S-C. Hepatoprotection of Graptopetalum paraguayense E. Walther on CCl4-induced liver damage and inflammation . J Ethnopharmacol. 2011;134:379–385.
   PubMed Web of Science ®Google Scholar
• Elion GB. Mechanism of action and selectivity of acyclovir. Am J Med. 1982;73:7–13.
   PubMed Web of Science ®Google Scholar
• Mudi SY, Ibrahim H. Activity of Bryophyllum pinnatum S. Kurz extracts on respiratory tract pathogenic bacteria. Bayero J Pure Appl Sci. 2008;1:43–48.
   Google Scholar
• Sonderholm M, Bjarnsholt T. The consequences of being in an infectious biofilm: microenvironmental conditions governing antibiotic tolerance. Int J Mol Sci. 2017;18:2688.
   Web of Science ®Google Scholar
• Bush K, Bradford PA. Beta-lactams and beta-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016;6:a025247.
   PubMed Web of Science ®Google Scholar